ReachMD CME

CME credits: 0.25 Valid until: 24-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/ready-set-act-opportunities-to-address-persistent-unmet-needs-in-patients-with-hfref-a-case-based-discussion/57260/ Using a real-world patient case, Dr. Stephen Greene and Dr. Carolyn Lam explore strategies to optimize care for patients with heart failure with reduced ejection fraction (HFrEF) who r...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/winning-the-ckd-ap-battle-a-united-physician-nurse-front/61000/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/what-you-dont-see-a-patients-view-of-living-with-ckd-ap/60999/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/reading-between-the-lines-what-proms-reveal-about-itch/60998/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/spotlight-on-assessment-tools-that-capture-ckd-ap/60997/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the s...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/from-scratch-to-strategy-talking-about-ckd-ap-in-clinical-practice/60996/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brie...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/gabapentinoids-safety-considerations-and-downstream-outcomes/60995/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lect...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/when-itching-hurts-quality-of-life-disruption-in-ckd-ap/60994/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/ckd-ap-uncovered-prevalence-pathophysiology/60993/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the series...

CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/frontline-champions-nurses-as-drivers-of-symptom-based-ckd-ap-care/54094/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brie...

CME credits: 0.50 Valid until: 10-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/menin-inhibitors-in-aml-six-clinical-showdowns-that-shape-real-world-practice/57259/ This chapterized expert interview examines six common clinical decision points encountered when incorporating menin inhibitors into the management of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). Fa...

CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-targeting-cdh6-in-platinum-resistant-ovarian-cancer/60967/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibi...

CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-strategies-for-her2-positive-platinum-resistant-ovarian-cancer/60966/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence s...

CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-strategies-for-fr-positive-platinum-resistant-ovarian-cancer/60965/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence sup...

CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-pd-l1guided-treatment-decisions-in-platinum-resistant-ovarian-cancer/60964/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence suppo...

CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/Case-Consult-Personalizing-First-Line-Maintenance-Therapy-in-Advanced-Ovarian-Cancer/60963/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence su...

CME credits: 0.25 Valid until: 31-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/rewriting-the-calcium-code-in-adh1/54833/ In this expert discussion, Drs. Michael Levine and Aliya Khan review emerging evidence in autosomal dominant hypocalcemia type 1 (ADH1), including findings from the CALIBRATE trial presented at ENDO 2026. They discuss how CaSR-targeted therapy with encaleret...

CME credits: 0.50 Valid until: 29-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/Redefining-Durability-in-nAMD-The-Science-and-Strategy-of-Sustained-Delivery-TKIs/59172/ While anti-VEGF biologics have transformed outcomes in neovascular age-related macular degeneration (nAMD), real-world data continue to show that visual gains achieved in clinical trials are not consistently rep...

CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/on-the-horizon-emerging-antigen-directed-strategies-across-disease-stage/60951/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antige...

CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/clinical-evidence-on-emerging-antigen-directed-strategies-in-es-sclc/60950/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens s...

CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/rationale-of-emerging-antigen-directed-strategies-in-frontline-es-sclc/60949/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens...

CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/the-survival-ceiling-in-es-sclc-why-checkpoint-blockade-alone-is-not-enough/60948/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting ant...

CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/translating-research-into-practice-in-breast-cancer-emerging-data-and-the-expanding-role-of-adcs/57226/ The role of antibody-drug conjugate (ADC) therapy has been well established in metastatic breast cancer. Recent phase 3 data have provided evidence for expanded indications for early breast cancer...

CME credits: 1.50 Valid until: 24-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/advancing-acromegaly-care-diving-deeper-into-diagnosis-guideline-application-and-emerging-therapiesa-fireside-chat-with-expert-perspectives/56307/ This program is a replay of the live symposium held at ENDO 2026. This program reviews challenges in diagnosis and management of acromegaly, with an emph...

CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/from-data-to-decision-patient-selection-and-real-world-application/60855/ This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...